Andrew Nicholson, Managing Director and Head of European Healthcare Investment Banking, and Alexandre Jourdan, Vice President, of Baird's Global Healthcare Investment Banking group recently sat down with HealthInvestor to discuss the current landscape of M&A activity in MedTech.

Nicholson and Jourdan share perspective on navigating the competitive MedTech landscape, what investors are looking for and their predictions for market momentum as we turn to the end of the year.

SUBSCRIBERS CAN READ THE FULL STORY

Andrew Nicholson
+44-20-7667-8509
anicholson@rwbaird.com

Alexandre Jourdan
+44-20-7667-8194
ajourdan@rwbaird.com